LLY - Performance Comparison: Eli Lilly and Co And Competitors In Pharmaceuticals Industry | Benzinga
In the ever-evolving and intensely competitive business landscape, conducting a thorough company analysis is of utmost importance for investors and industry followers. In this article, we will carry out an in-depth industry comparison, assessing Eli Lilly and Co (NYSE:LLY) alongside its primary competitors in the Pharmaceuticals industry. By meticulously examining key financial metrics, market positioning, and growth prospects, we aim to offer valuable insights to investors and shed light on company's performance within the industry.
Eli Lilly and Co Background
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
| Company | P/E | P/B | P/S | ROE | EBITDA (in billions) | Gross Profit (in billions) | Revenue Growth |
|---|---|---|---|---|---|---|---|
| Eli Lilly and Co | |||||||
| 120.04 | |||||||
| 60.46 | |||||||
| 20.49 | |||||||
| 19.02% | |||||||
| $3.12 | |||||||
| $7.09 | |||||||
| 25.98% | |||||||
| Novo Nordisk A/S | |||||||
| 45.86 | |||||||
| 41.12 | |||||||
| 16.76 | |||||||
| 24.73% | |||||||
| $36.91 | |||||||
| $55.43 | |||||||
| 22.45% | |||||||
| Johnson & Johnson | |||||||
| 21.59 | |||||||
| 4.99 | |||||||
| 4.27 | |||||||
| 4.69% | |||||||
| $5.68 | |||||||
| $14.87 | |||||||
| 2.34% | |||||||
| Merck & Co Inc | |||||||
| 138.37 | |||||||
| 7.81 | |||||||
| 5.16 | |||||||
| 12.22% | |||||||
| $6.96 | |||||||
| $12.23 | |||||||
| 8.89% | |||||||
| AstraZeneca PLC | |||||||
| 37.91 | |||||||
| 6.36 | |||||||
| 5.04 | |||||||
| 5.69% | |||||||
| $4.47 | |||||||
| $10.46 | |||||||
| 16.55% | |||||||
| Novartis AG | |||||||
| 22.89 | |||||||
| 5.18 | |||||||
| 4.38 | |||||||
| 6.23% | |||||||
| $4.66 | |||||||
| $9.02 | |||||||
| 9.71% | |||||||
| GSK PLC | |||||||
| 15.86 | |||||||
| 5.08 | |||||||
| 2.31 | |||||||
| 2.64% | |||||||
| $2.07 | |||||||
| $5.39 | |||||||
| 9.16% | |||||||
| Zoetis Inc | |||||||
| 32.65 | |||||||
| 15.29 | |||||||
| 8.94 | |||||||
| 11.91% | |||||||
| $0.93 | |||||||
| $1.55 | |||||||
| 9.5% | |||||||
| Takeda Pharmaceutical Co Ltd | |||||||
| 44.96 | |||||||
| 0.88 | |||||||
| 1.52 | |||||||
| -0.04% | |||||||
| $186.41 | |||||||
| $668.37 | |||||||
| -5.43% | |||||||
| Dr Reddy's Laboratories Ltd | |||||||
| 17.37 | |||||||
| 3.43 | |||||||
| 3.47 | |||||||
| 4.76% | |||||||
| $20.32 | |||||||
| $49.91 | |||||||
| -1.83% | |||||||
| Jazz Pharmaceuticals PLC | |||||||
| 21.83 | |||||||
| 1.80 | |||||||
| 1.90 | |||||||
| -0.39% | |||||||
| $0.23 | |||||||
| $0.81 | |||||||
| 1.03% | |||||||
| Corcept Therapeutics Inc | |||||||
| 29.72 | |||||||
| 5.93 | |||||||
| 6.58 | |||||||
| 5.22% | |||||||
| $0.03 | |||||||
| $0.14 | |||||||
| 38.95% | |||||||
| Prestige Consumer Healthcare Inc | |||||||
| 15.06 | |||||||
| 1.89 | |||||||
| 2.80 | |||||||
| 3.04% | |||||||
| $0.09 | |||||||
| $0.15 | |||||||
| -3.11% | |||||||
| Indivior PLC | |||||||
| 451.75 | |||||||
| 243.56 | |||||||
| 2.27 | |||||||
| 940.0% | |||||||
| $0.08 | |||||||
| $0.24 | |||||||
| 12.25% | |||||||
| Average | |||||||
| 68.91 | |||||||
| 26.41 | |||||||
| 5.03 | |||||||
| 78.52% | |||||||
| $20.68 | |||||||
| $63.74 | |||||||
| 9.27% |